5 Results for "

Elafibranor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Elafibranor" in MCE Product Catalog:

16
16 Cited Publications
Cat. No.: HY-16737
CAS No.: 923978-27-2
Synonyms: GFT505
Target:  

PPAR

Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
Cat. No.: HY-176510
Elafibranor (GFT505) sulfoxide is a sulfoxide metabolite of Elafibranor (HY-16737). Elafibranor is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
Cat. No.: HY-16737R
CAS No.: 923978-27-2
Synonyms: GFT505 (Standard)
Elafibranor (Standard) is the analytical standard of Elafibranor. This product is intended for research and analytical applications. Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
Cat. No.: HY-16737A
CAS No.: 824932-88-9
Synonyms: (E/Z)-GFT505
Target:  

PPAR

Research Areas:  

Metabolic Disease

(E/Z)-Elafibranor ((E/Z)-GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively .
loading...
    loading...
Cat. No.: HY-155525
CAS No.: 2409685-41-0
Purity:  98.49%
Target:  

PPAR

Anti-NASH agent 1 (compound 3d),a derivative of Elafibranor (HY-16737),is a potent agonist of PPAR-α/δ,targeting to nonalcoholic steatohepatitis (NASH). Anti-NASH agent 1 (3-10 mg/kg; 4 weeks) improves hyperlipidemia,liver fat degeneration and liver inflammation in Methionine-choline deficiency (MCD) induced NASH mice model. Anti-NASH agent 1 shows low liver toxicity and potent liver protection effect .
loading...
    loading...